Toho Holdings CoTSE:8129 -0.05%85 ROA % is 1.47% as of Mar. 2026, which is 36% below its 10-year median of 2.30. GuruFocus rates TSE:8129 with a GF Score™ of 85/100 and a GF Value™ of 円4,792.65 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, Toho Holdings Co ranks better than 52.54% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Toho Holdings Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円11,516 Mil.
Toho Holdings Co's average Total Assets over the quarter that ended in Mar. 2026 was 円783,439 Mil. Therefore, Toho Holdings Co's annualized ROA % for the quarter that ended in Mar. 2026 was 1.47%.
The historical rank and industry rank for Toho Holdings Co's ROA % or its related term are showing as below:
TSE:8129'
s ROA % Range Over the Past 10 Years
Min: 0.74 Med: 2.3 Max: 2.78
Current: 2.29
During the past 13 years, Toho Holdings Co's highest ROA % was 2.78%. The lowest was 0.74%. And the median was 2.30%.
TSE:8129's ROA % is ranked better than 52.54% of 118
companies
in the Medical Distribution industry
Industry Median: 2.215
vs TSE:8129: 2.29
Toho Holdings Co (TSE:8129) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Toho Holdings Co ROA % Related Terms
Toho Holdings Co ROA % Historical Data
* Premium members only.
The historical data trend for Toho Holdings Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Toho Holdings Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Toho Holdings Co ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's ROA % distribution charts can be found below:
* The bar in red indicates where Toho Holdings Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Toho Holdings Co (TSE:8129) has a ROA % of 1.47% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Toho Holdings Co and its competitors. This is 36% below median its historical median of 2.30. Over the past decade, Toho Holdings Co's ROA % has ranged from 0.74 to 2.78. According to the industry distribution chart, Toho Holdings Co ranks #56 out of 118 companies in the Medical Distribution industry, placing it in the top 47.5%.
Is Toho Holdings Co's ROA % too high?
Toho Holdings Co's current ROA % of 1.47% is 36% below median its 10-year median of 2.30. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 2.78. The Medical Distribution industry median ROA % is 2.22. Toho Holdings Co's value of 1.47% is 33.6% below this industry median. Based on the distribution chart, Toho Holdings Co ranks #56 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Toho Holdings Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's ROA % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #56 out of 118 companies for ROA %. This puts Toho Holdings Co in the upper half of its industry. The industry median ROA % is 2.22. Toho Holdings Co's value of 1.47% is 33.6% below this benchmark. Historically, Toho Holdings Co's own ROA % has ranged from 0.74 to 2.78 over the past decade. While the company's 10-year median is 2.30 vs. the industry median of 2.22, Toho Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.22, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Toho Holdings Co's current ROA % of 1.47% is 33.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Toho Holdings Co and its competitors. For the Medical Distribution industry, the median ROA % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current ROA % is 1.47%, which is 36% below median its own 10-year median of 2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Toho Holdings Co (TSE:8129) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,792.65, compared to a current price of 円4,010.00 — trading 16.3% below its estimated fair value. The current ROA % is 1.47%, which is 36% below median its 10-year median of 2.30 and 33.6% below the Medical Distribution industry median of 2.22. Toho Holdings Co's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Toho Holdings Co (TSE:8129), the current ROA % is 1.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Toho Holdings Co (TSE:8129) Overvalued in 2026?
Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued.
The current stock price of 円4,010.00 is trading 16.3% below its estimated GF Value™ of 円4,792.65.
GuruFocus considers Toho Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:8129:
ROA %: 1.47% (36% below median its 10-year median of 2.30)
GF Value™: 円4,792.65 vs. price of 円4,010.00 (16.3% below fair value)
Industry Position: 33.6% below the Medical Distribution median (#56 of 118)
No single metric tells the full story. See the TSE:8129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
85GF Score
Get the complete analysis for TSE:8129
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8129 has been successfully added to your 
